Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
07/13/2005 | EP1552024A2 Compositions and methods for determining the replication capacity of a pathogenic virus |
07/13/2005 | EP1551992A2 Screening molecules with anti-prion activity: kits, methods and screened molecules |
07/13/2005 | EP1551988A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
07/13/2005 | EP1551977A1 Selective, local activation of members of the tnf ligand family of systemically inactive non-antibody tnf ligand fusion proteins |
07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
07/13/2005 | EP1551975A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
07/13/2005 | EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
07/13/2005 | EP1551969A1 A method of altering levels of plasmids |
07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
07/13/2005 | EP1551957A2 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
07/13/2005 | EP1551951A1 Genetically modified microorganisms, plasmid and fermentation process with the presence of flocculation regulated by medium changes |
07/13/2005 | EP1551872A2 G-protein coupled receptors |
07/13/2005 | EP1551859A2 Aav itr-mediated modulation |
07/13/2005 | EP1551858A2 Dna and amino acid sequences of a tyrosine ammonia lyase enzyme from the bacterium rhodobacter sphaeroides |
07/13/2005 | EP1551857A2 A robust, inducible cardiac preferred expression system for transgenesis |
07/13/2005 | EP1551439A2 Improved systems and methods for analysis of protein post-translational modification |
07/13/2005 | EP1551434A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
07/13/2005 | EP1551291A2 Method for obtaining dynamic and structural data pertaining to proteins and protein/ligand complexes |
07/13/2005 | EP1551225A2 Cryopreservation of haptenized tumor cells |
07/13/2005 | EP1204608B9 Method of purifying water, suitable bacteria for the method and use thereof |
07/13/2005 | EP0938308B1 Antiparasitic agents |
07/13/2005 | EP0804548B1 Patched genes and their use |
07/13/2005 | EP0698099B1 Method for the culture in vitro of different stages of tissue parasites |
07/13/2005 | CN1639570A Proteins with repetitive bacterial-ig-like (BIG) domains present in leptospira species |
07/13/2005 | CN1639353A Method for producing riboflavin |
07/13/2005 | CN1639350A Amino acid-producing bacteria and a process for preparing L-amino acids |
07/13/2005 | CN1639349A Microorganisms and processes for enhanced production of pantothenate |
07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
07/13/2005 | CN1639341A Process for producing L-threonine with the use of bacterium belonging to the genus escherichia |
07/13/2005 | CN1639340A Method of controlling ethanol production |
07/13/2005 | CN1639339A Fermentation process |
07/13/2005 | CN1639338A Modified Cry3A toxins and nucleic acid sequences coding therefor |
07/13/2005 | CN1639328A Novel dehydrogenase and gene encoding the same |
07/13/2005 | CN1639322A Recombinant spores |
07/13/2005 | CN1639321A Bacterial spores |
07/13/2005 | CN1639320A Cold shock inducible expression and production of heterologous polypeptides |
07/13/2005 | CN1639319A Secondary metabolite congener distribution modulation |
07/13/2005 | CN1639318A Antimicrobial composition |
07/13/2005 | CN1639317A Probiotic lactobacillus salivarius strains |
07/13/2005 | CN1639195A Selective targeting of tumor vasculature using antibody molecules |
07/13/2005 | CN1639192A Anti-human tenascin monoclonal antibody |
07/13/2005 | CN1639183A Secretion, transcription and sporulation genes in bacillus clausii |
07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
07/13/2005 | CN1637145A Method of expressing human apolipoprotein ApoA I inside Pichia yeast cell |
07/13/2005 | CN1637143A Correlation gene for generating synthetic cholesterol synthetic inhibitor monakalin k |
07/13/2005 | CN1637135A Attenuated eel vibrio strain and its application |
07/13/2005 | CN1637134A Method of encysting liquid core lactic acid bacteria and leaven produced thereby |
07/13/2005 | CN1637133A Banana endophyte and its use |
07/13/2005 | CN1636603A Deodorizing agent containing dry cell of microorganism as active ingredient and deodorizing method |
07/13/2005 | CN1210403C Method for producing biotin |
07/13/2005 | CN1210402C Broad-spectrum delta-enotoxins |
07/13/2005 | CN1210401C Compound from moraxella catarrhalis |
07/13/2005 | CN1210397C Method for producing threonine and isolenine |
07/13/2005 | CN1210396C L-amino acid-producing bacteria and process for producing L-amino acid |
07/13/2005 | CN1210395C Heterotrophic nitrobacteria, culturing method and application thereof |
07/13/2005 | CN1210394C Natural inductive non bean family plant tumour forming nitrogen fixation technical method and bacterial spawn |
07/13/2005 | CN1210393C Technique of preparing fermentation culture medium for microbe |
07/13/2005 | CN1210304C Sequence number 3 bioactive peptide |
07/13/2005 | CN1210301C Bioactive peptide sequential No.18 |
07/13/2005 | CN1210300C Bioactive peptide No.29 |
07/13/2005 | CN1210299C Sequence No.19 biological active peptide |
07/13/2005 | CN1210298C Sequence number 1 bioactive peptide |
07/13/2005 | CN1210297C Bioactive peptide sequential No.17 |
07/13/2005 | CN1210296C Sequential bioactive peptide No.30 |
07/13/2005 | CN1210295C Sequential No.24 bioactive peptide |
07/13/2005 | CN1210294C Sequential No.21 bioactive peptide |
07/13/2005 | CN1210293C Sequential No.23 bioactive peptide |
07/13/2005 | CN1210292C Bioactive peptide sequential No.22 |
07/13/2005 | CN1210208C Feed additives containing yeast microelement chelates and production thereof |
07/13/2005 | CN1210062C Pig erysipelothrix rhusiopathiae antigen and vaccine composition thereof |
07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
07/12/2005 | US6916782 Gene coding for heliomicine and use thereof |
07/12/2005 | US6916651 Heat treated immobilized microorganism support for enviroment remediation |
07/12/2005 | US6916650 Pseudomonas used for the treatment of plants and/or seeds and incubated in a culture containing phosphorus compounds, nitrogen compounds and succinic acid |
07/12/2005 | US6916647 Lactococcus for preserving foodstuffs or animal feed and preventing food-poisoning |
07/12/2005 | US6916641 (R)-2-hydroxy-3-phenylpropionate (d-phenyllactate) dehydrogenase and gene encoding the same |
07/12/2005 | US6916632 Generation of preferential configured nucleotide sequences; obtain nucleotide sequences, incubate with topoisomerase, link sequences and recover products |
07/12/2005 | US6916629 Tissue factor pathway inhibitor-3 |
07/12/2005 | US6916623 Generation of soluble protein; obtain vector, incubate with nucleotide sequnces coding protein domains, digest sequences, ligate, express vector in cell free system, recover protein |
07/12/2005 | US6916615 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
07/12/2005 | US6916609 Comprises nucleotide sequences coding chaperone protein for diagnosis, prevention and treatment of cancer, immunological and inflammatory diseases |
07/12/2005 | US6916608 Stabilizing agents for preventing the degradation of nucleotide sequences during analysis |
07/12/2005 | US6916478 Prevention, therapy infectious diseases; insertion of nucleic acids into target cells |
07/12/2005 | US6916477 Vaccine containing attenuated virus; induction antibodies; veterinary medicine |
07/12/2005 | US6916474 Binds immunologically to bacillus anthracis protective antigen with an affinity kd of 140-21 pm determined by surface plasmon resonance |
07/12/2005 | US6916462 Administering conjugate of the entity and a light-generating moiety; immobilizing the subject within the detection field of a photodetector device; measuring photon emission with photodetectorl; constructing image |
07/12/2005 | CA2432123C Preservation of cells |
07/12/2005 | CA2156066C An enzyme feed additive and animal feed including it |
07/12/2005 | CA1341485C Fusion proteins utilizing the decay accelerating factor membrane binding domain |
07/07/2005 | WO2005061716A2 Expression vector used for antibiotic-free expression |
07/07/2005 | WO2005061541A1 Anti-igf-i receptor antibody |
07/07/2005 | WO2005060937A1 Compressed tablets comprising viable probiotic microorganisms |
07/07/2005 | WO2005060757A1 Liquid leaven composition |
07/07/2005 | WO2005060709A2 Methods of use of probiotic bifidobacteria for companion animals |
07/07/2005 | WO2005060708A2 Canine probiotic lactobacilli |
07/07/2005 | WO2005060498A2 Composition and method for inhibiting salmonella and campylobacter colonization in poultry |
07/07/2005 | WO2005044844A3 Protozoan strains of reduced virulence and use thereof |
07/07/2005 | WO2005017095A3 A stable liquid probiotic composition, preparation and applications thereof |
07/07/2005 | WO2004085666A3 Secreted proteins |
07/07/2005 | US20050150005 DNA construct to confer multiple traits on plants |